4-methoxyestradiol has been researched along with Adenocarcinoma Of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, I; Chiyomaru, T; Dahiya, R; Deng, G; Liu, J; Majid, S; Saini, S; Shahryari, V; Tanaka, Y; Yamamura, S; Zaman, MS | 1 |
1 other study(ies) available for 4-methoxyestradiol and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.
Topics: Apoptosis; Carcinoma, Renal Cell; Catechol O-Methyltransferase; Cell Cycle Proteins; Cell Death; Cell Growth Processes; Cell Line; Cell Line, Tumor; Down-Regulation; Estradiol; Estrogens, Catechol; Humans; Kidney Neoplasms; Nuclear Proteins; RNA, Messenger; Up-Regulation | 2012 |